Cytokine & Chemokine Modulation TB-500 has been shown to modulate the expression of several cytokines in laboratory models: Anti-Inflammatory Signaling In preclinical models, TB-500 has been observed to reduce the expression of pro-inflammatory mediators while promoting the activity of anti-inflammatory cytokines
Innovations in GLP-1 Agonist Therapies The success of GLP-1 agonists in both diabetes management and weight loss has spurred further innovation in this drug class, leading to the development of new generations with improved efficacy, safety, and patient convenience
29.7 mg/dL
Thymosin beta-4 exhibits a broader range of biological actions due to its extended sequence and additional regulatory motifs, while TB-500 provides a simplified, targeted model for studying actin-binding and local regeneration processes
Instead of working through gut hormone pathways, it acts directly on the brains neurotransmitter systems specifically by blocking the reuptake of three key brain chemicals: serotonin, dopamine, and noradrenaline
At Siti Med Spa in San Diego, we have seen patients whose lifelong struggle with weight loss suddenly turned the corner after they began receiving regular vitamin B12 injections
